Frailty, nutritional status, and inflammation as determinants of chemotherapy delivery and outcomes in pancreatic cancer patients receiving gemcitabine plus nab-paclitaxel.

Saved in:
Bibliographic Details
Title: Frailty, nutritional status, and inflammation as determinants of chemotherapy delivery and outcomes in pancreatic cancer patients receiving gemcitabine plus nab-paclitaxel.
Authors: Lee HS; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea., Jeong CM; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea., Lee JM; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.; College of Medicine, Korea University, Seoul, Republic of Korea., Kim TI; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea., Kim SH; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea., Jeon HJ; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.; College of Medicine, Korea University, Seoul, Republic of Korea., Choi HS; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.; College of Medicine, Korea University, Seoul, Republic of Korea., Kim ES; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.; College of Medicine, Korea University, Seoul, Republic of Korea., Keum B; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.; College of Medicine, Korea University, Seoul, Republic of Korea., Jeen YT; Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.; College of Medicine, Korea University, Seoul, Republic of Korea.
Source: Frontiers in oncology [Front Oncol] 2026 Mar 16; Vol. 16, pp. 1730394. Date of Electronic Publication: 2026 Mar 16 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1730394